Invicta Diagnostic IPO GMP & Review: Apply or Avoid?

The Invicta Diagnostic IPO is open for bidding from 1st December 2025 to 3rd December 2025. It is a bookbuilding IPO of ₹28.12 crore and entirely a fresh issue worth ₹33,00,000 shares. The issue will be listed on NSE and SME on its tentative listing date, 8th December 2025. 

Invicta Diagnostic IPO Details 

The Invicta Diagnostic IPO date is fixed between 1st December 2025 and 3rd December 2025. The face value of Invicta Diagnostic shares stands at ₹10 per share, and the IPO Issue price band is set at ₹80 to ₹85 per share

Bigshare Services Private Limited is the registrar of the Invicta Diagnostic IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Invicta Diagnostic IPO Share Reservation

Invicta Diagnostic IPO is a bookbuilding IPO issue of 33,00,000 shares worth ₹28.12 crores. Invicta Diagnostic IPO Limited shares will be listed on the BSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Invicta Diagnostic IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Invicta Diagnostic IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 1st December 2025, Invicta Diagnostic IPO GMP stands at ₹0 per share, which means the share will likely show a listing at ₹85 on its tentative listing date, 8th December 2025.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Invicta Diagnostic IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends. 

Invicta Diagnostic IPO GMP Review

Check out the detailed Invicta Diagnostic GMP IPO review for a thorough understanding of its potential to report listing gains on 8th December 2025. The Invicta Diagnostic IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business’s economic growth and decline before applying for the Invicta Diagnostic IPO.

Invicta Diagnostic  Limited’s revenue soared by 90% from ₹15.90 crores in March 2024  to ₹30.18 crores in March 2025. Moreover, the company’s PAT increased by 30% from ₹3.81 crores in March 2024 to ₹4.93 crores in March 2025.

Invicta Diagnostic  Ipo has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for the Invicta Diagnostic IPO for its tentative listing day, which is 8th December 2025. 

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Invicta Diagnostic IPO.

The PE ratio of Invicta Diagnostic Limited shares is 15.97, and its Earnings Per Share (EPS) stands at 5.32. Thus, the Invicta Diagnostic IPO can potentially deliver gains on its tentative listing date, 8th December 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Invicta Diagnostic  Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Invicta Diagnostic IPO Subscription Status

The Invicta Diagnostic IPO is to be opened for bidding on 1st December 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Invicta Diagnostic IPO Subscription Status. 

About Invicta Diagnostic Limited

Invicta Diagnostics was established in January 2021. Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand ‘PC Diagnostics’ through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra. Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:

1. Flagship Hub
2. Three additional hubs are Bhayandar, Byculla, and Marol
3. Three spokes in Lower Parel, Sewri and Kalwa

The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.

Invicta Diagnostic  Limited Financials

The company’s financial analysis is essential before applying for the Invicta Diagnostic IPO. Look at the table to learn about Invicta Diagnostic  Limited’s financials. 

Explanation

Invicta Diagnostic  Limited’s revenue soared by 90% from ₹15.90 crores in March 2024  to ₹30.18 crores in March 2025. Moreover, the company’s PAT increased by 30% from ₹3.81 crores in March 2024 to ₹4.93 crores in March 2025.

Invicta Diagnostic IPO Bidding Requirements

Investors can bid for a Minimum of 3,200 shares in multiples of 1,600 Shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

The Invicta Diagnostic IPO has reserved lot sizes to be applied by different investor categories. Look at the table below to know about the requirements to be fulfilled for applying for this IPO.

Use the lot size calculator to find how many shares you should apply!

Invicta Diagnostic  Limited IPO Promoter Holdings

Have a look at the table below to check the holdings of Invicta Diagnostic Limited. Dr Ketan Jayantilal Jain, Dr Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi and Jayesh Prakash Jain are the promoters of the company.

Note: The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue.

Aim of Invicta Diagnostic IPO

The primary aim of the Invicta Diagnostic IPO is to raise ₹28.12 crores. On the other hand, Invicta Diagnostic has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Invicta Diagnostic IPO.

• Funding capital expenditure for the purchase of medical equipment towards the establishment of five new diagnostic centres in Maharashtra
• General Corporate purposes

Should I Invest in the Invicta Diagnostic IPO?

MSECL is one of the leading comprehensive consultancy service providers with all related aspects. It marked growth in its top and bottom lines for the reported periods. It can generate higher margins because of its capability to provide all related services under one roof. Based on recent financial data, the issue appears reasonably priced. Investors may park funds for medium- to long-term investments. ~Dilip Davda (Chief Editor at Chittorgarh)

Explore the pros and cons of the Invicta Diagnostic to know whether you should apply or avoid the issue. These pros and cons might help you know about the IPO’s efficiency in delivering profits in the coming decades. 

Pros of the Invicta Diagnostic IPO

1. The company has an expanding presence in the Mumbai Metropolitan region, especially in radiology.
2. The company has technical capabilities and technology, including an IT infrastructure.
3. The company is a dedicated management team with significant industry experience.

Cons of the Invicta Diagnostic  IPO

1. The company has a high dependence on radiology 
2. The company has operational risks and a single hub dependence 
3. The company has geographic concentration risk

How to Apply for Invicta Diagnostic IPO?

Follow the steps below to apply for Invicta Diagnostic Ltd.

• Step 1: Conduct thorough research on the Invicta Diagnostic IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account on Univest to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for two lots of 3,200 shares worth ₹2,72,000
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Invicta Diagnostic IPO from more than one demat account to increase your allotment chances. 

How to Check Invicta Diagnostic IPO Allotment Status?

You can check for the Invicta Diagnostic IPO allotment in different ways. These include BSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On NSE

• Visit the NSE Official Site
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Invicta Diagnostic IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Invicta Diagnostic IPO allotment status.

Let’s Wrap

The Invicta Diagnostic IPO is a bookbuilding issue of shares worth ₹28.12 crores. The shares of Invicta Diagnostic  Limited will be listed on BSE and SME on its tentative listing date of 8th December 2025. Researching the Invicta Diagnostic IPO GMP and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Invicta Diagnostic IPO

How is the Invicta Diagnostic IPO?

Ans. Currently, on 1st December 2025, the Invicta Diagnostic GMP (Grey Market Premium) stands at ₹0. It indicates that the estimated listing price could be ₹85 per share. It is a bookbuilding IPO of 33.00 lakh shares worth ₹28.12 crores. The face value of each Invicta Diagnostic share is ₹10. 

What is the Invicta Diagnostic IPO price?

Ans. The Invicta Diagnostic IPO issue price band is set at ₹80 to ₹85 per share. Retail investors can apply for a minimum of 2 lots consisting of 3,200 shares worth ₹2,72,000. Moreover, HNIs are required to bid for a minimum of 3 lots (4,800 shares) worth ₹4,08,000.

Is the Invicta Diagnostic IPO good?

Ans. Invicta Diagnostic  Limited’s revenue soared by 90% from ₹15.90 crores in March 2024  to ₹30.18 crores in March 2025. Moreover, the company’s PAT increased by 30% from ₹3.81 crores in March 2024 to ₹4.93 crores in March 2025.

Who is the registrar of the Invicta Diagnostic IPO?

Ans.  Bigshare Services Pvt Limited is the registrar for the Invicta Diagnostic IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Invicta Diagnostic allotment and refund, you can contact Bigshare Services Pvt. Ltd. at ipo@bigshareonline.com or +91-22-6263 8200.

What is the issue size of the Invicta Diagnostic IPO? 

Ans. Invicta Diagnostic IPO is a bookbuilding IPO for 33.00 lakh shares worth ₹28.12 crore. Moreover, the IPO is set to open on 1st December 2025 and will be closed on 3rd December 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Invicta Diagnostic IPO, download the Invicta Diagnostic IPO RHP and Invicta Diagnostic IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest In India

Also Explore

Univest Screeners

Explore Webstories on Univest 

Best Time To Buy Dividend Stocks

How RBI Policies Affect Dividend Stocks

Can Dividend Stocks Beat Inflation

What Is The Dividend Aristocrat List

Which Indian Psus Offer The Best Dividends

Large Cap Vs Small Cap Dividend Stocks